EMA Approves Factor VIII Deficiency Clotting Drug EMA Approves Factor VIII Deficiency Clotting Drug

European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news